Malignant melanoma: Impact of superficial US on management

Radiology

Volumn 199, Issue 1, 1996, Pages 273-277

  Nazarian, Levon N ^a   Alexander, Archie A ^a   Rawool, Nandkumar M ^a   Kurtz, Alfred B ^a   Maguire, Henry C ^a   Mastrangelo, Michael J ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Melanoma; Skin, US; Soft tissues, US

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MEDICAL DECISION MAKING; MELANOMA; PRIORITY JOURNAL; SOFT TISSUE TUMOR; TUMOR BIOPSY;

EID: 0029983349     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.199.1.8633159     Document Type: Article

References (21)

1. Harris MN, Shapiro RL, Roses DF. Malignant melanoma: primary surgical management (excision and node dissection) based on pathology and staging. Cancer 1995; 75:715-725.
2. Horgan K, Hughes LE. Review, staging of melanoma. Clin Radiol 1993; 48:297-300.
3. Lee YN. Malignant melanoma: pattern of metastasis. CA Cancer J Clin 1980; 30:137-142.
4. Yeung RSW. Recurrent cutaneous melanoma: a surgical perspective. Semin Oncol 1993; 20:400-418.
5. McCarthy WH, Thompson JF, Milton GW, et al. Time and frequency of recurrence of cutaneous stage 1 malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet 1988; 166:497-502.
6. Lee YN. Loco-regional primary and recurrent melanoma. III. Update of natural history and non-systemic treatments (1980-1987). Cancer Treat Rev 1988; 15: 135-162.
7. Reintgen DS, Vollmer R, Tso CY, et al. Prognosis for recurrent stage I malignant melanoma. Arch Surg 1987; 122:1338-1342.
8. Patten RM, Shuman WP, Teefey S. Subcutaneous metastases from malignant melanoma: prevalence and findings on CT. AJR 1989; 152:1009-1012.
9. Das Gupta T, Brasfield R. Metastatic melanoma: a clinicopathological study. Cancer 1964; 17:1323-1339.
10. Legha SS. Current therapy for malignant melanoma. Semin Oncol 1989; 16:34-44.
11. Coit DG. Role of surgery for metastatic malignant melanoma: a review. Semin Surg Oncol 1993; 9:239-245.
12. Fornage BD, Lorigan JG. Sonographic detection and fine-needle aspiration biopsy of nonpalpable recurrent or metastatic melanoma in subcutaneous tissues. J Ultrasound Med 1989; 8:421-424.
13. Lange TA, Austin CW, Seibert JJ, Angtuaco TL, Yandow SR. Ultrasound imaging as a screening study for malignant soft-tissue tumors. J Bone Joint Surg [Am] 1987; 69: 100-105.
14. van den Brekel MWM, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990; 177:379-384.
15. Bruneton JN, Balu-Maestro C, Marcy PY, Melia P, Mourou MY. Very high frequency (13 MHz) ultrasonographic examination of the normal neck: detection of normal lymph nodes and thyroid nodules. J Ultrasound Med 1994; 13:87-90.
16. Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 1992; 183: 215-220.
17. Ho VC, Sober AJ. Therapy for cutaneous melanoma: an update. J Am Acad Dermatol 1990; 22:159-176.
18. Berman C, Reinigen D. Radiologic imaging in malignant melanoma: a review. Semin Surg Oncol 1993; 9:232-238.
19. Jacobson HG, Edeiden J. The use of computed body tomography in malignant melanoma. JAMA 1988; 259:2896-2897.
20. Shirkhoda A, Albin J. Malignant melanoma: correlating abdominal and pelvic CT with clinical staging. Radiology 1987; 165: 75-78.
21. Srivastava A, Hughes LE, Woodcock JP, Laidler P. Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumour behaviour. Br J Cancer 1989; 59: 89-91.